Continuing Medical Education
School of Medicine, UAB
   
Course Catalog
Back to Online Courses
Online CME Courses
Polypharmacy in the Elderly


Certified for 1 AMA PRA Category 1 Credit


Co-Sponsored by the University of Alabama School of Medicine
Division of Continuing Medical Education,
Division of Gerontology, Geriatrics, and Palliative Care, and
The Center for Aging

Release Date: February 5, 2007
Expiration Date: February 5, 2010

TARGET AUDIENCE:
Primary care physicians

OBJECTIVES:
Upon completion of this CME activity, clinicians should be able to:
  • Define polypharmacy.
  • Describe age-related changes in drug metabolism.
  • Recognize delirium as a common adverse drug event.
  • List the side-effects of anticholinergic medications.
  • List prescribing practices that help reduce the risk of an adverse drug event in older adults.
Top of Page

SOURCE:
EDITOR AND CONTRIBUTING AUTHOR:

Angela R. Curtis, PhD
Managing Editor
Assistant Professor, Geriatric Education Manager

Kellie L. Flood, MD
Assistant Professor

Division of Gerontology, Geriatrics and Palliative Care
University of Alabama at Birmingham
Birmingham, Alabama

Top of Page

DISCLOSURE:

The faculty has no commercial affiliations to disclose.

Because of the nature of preliminary studies, some products mentioned are unlabeled and investigational. Dosages, indications, and methods of use of drugs mentioned in this publication may reflect the experience of the authors, clinical literature, or other resources. Therefore, please see the full prescribing information before using any licensed product mentioned.

Top of Page

CME PARTICIPATION:
To participate in this program for CME credit, please review the objectives before beginning the program. Take the course, complete the case questions and evaluation before February 5, 2010 to receive CME credit. Your certificate will then be available online. This process should take approximately 60 minutes.

ACCREDITATION:

The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Alabama School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The boards of nursing in many states, including Alabama, recognize Category 1 continuing medical education courses as acceptable activities for the renewal of license to practice nursing.

Top of Page

INTRODUCTION:

The term “polypharmacy” may be defined several different ways and may refer to:

  • The use of many medications at the same time
  • Prescribing more medication than is clinically indicate
  • A regimen that includes at least one inappropriate medication
  • The use of 5 or more medications[1]
Top of Page

Case:

Mrs. M is an 80 year old African American woman who is a new patient to your office. She has a history of mild Alzheimer’s dementia, hypothyroidism, hypertension, recurrent UTIs, and depression. Her daughters brought her to see you for a second opinion. The patient has been experiencing diarrhea for the last 3 months, worsening weakness, falling, and increased confusion.

The family reports that Mrs. M moved into an assisted living facility about 1 year ago because of difficulty caring for herself at home. She is widowed had to quit driving several years ago due to episodes of getting lost and near accidents. After moving into the assisted living facility Mrs. M made new friends and seemed to adapt well at first. But four months ago Mrs. M complained of sadness, which she attributed to the deaths of several friends and relatives. Her prior physician started her on sertraline for depression. He scheduled her for follow-up in 3 months, but she returned to see him in 1 month because of diarrhea. She previously had a BM every 1-2 days, but now has 3-5 loose stools daily. There is no melena or hematochezia, and a thorough evaluation revealed no evidence of infection, metabolic abnormality, or malignancy. Three months ago she was prescribed clidinium/chlordiazepoxide (Librax) twice daily as needed for diarrhea. The diarrhea continued so her physician told her she could also take diphenoxylate/atropine (Lomotil) 1-2 tabs tid-qid prn diarrhea. One month ago she started having trouble making to the bathroom on time and had several episodes of fecal incontinence at night. She said that she just felt too weak to be able to rush to the bathroom. Her doctor added hyoscyamine (Levsin) at bedtime. The diarrhea has decreased to only twice a day and she still has no melena or hematochezia.

Her current medications are:

Aricept (Donepezil) 10mg po daily for 2 years
Synthroid (Levothyroxine) 0.05mg po daily for 5 years
Lasix (Furosemide) 40mg po daily for 1 year
KCl 10meq po daily for 1 year
Toprol XL (Metoprolol) 50mg po daily for 7 years
Bactrim DS (Trimethoprim/sulfamethoxazole) one tablet po daily for 1 year
Zoloft (Sertraline) 50 mg po daily for 5 months
Librax [Clidinium/chlordiazepoxide (Librium)] 1 tab bid prn for 3 months
Lomotil (Diphenoxylate/atropine) 1-2 tabs tid-qid prn for 2 months
Levsin (Hyoscyamine) one tab po qhs for 1 month

On physical exam Mrs. M is an elderly woman looking her stated age, slumped in wheelchair, generally lethargic, but in no acute distress, clean and well-groomed. Her vital signs are:

Wt 120 lbs., ht 5’5”, T 37.6, RR 18, HR 45
BP seated 130/70, standing 100/55 (with symptoms of lightheadedness)

Other notable findings include dry mucus membranes, normal thyroid exam, and bradycardia without murmurs. Abdominal exam reveals normal, active bowel sounds, moderately distended but non-tender with no hepatosplenomegaly. Rectal exam reveals no masses and guaiac negative brown stool. Neurologic exam reveals the patient is lethargic, arouses to voice, but is inattentive, oriented only to name. Cranial nerves are intact, muscle tone is normal without tremor, cogwheeling, or rigidity, and reflexes are 1+ symmetric throughout. The patient requires assistance of 2 people to stand, Romberg is positive with eyes open, and she is too lightheaded to walk.

Top of Page

Case, Question 1 of 5

1. Which of the following statements is FALSE?

A. Pharmacokinetics studies the time a drug and its metabolites are present in an organ system or body.
B. Pharmacodynamics refers to the action of a drug or its metabolites on an organ system or body.
C. Distribution refers to the locations in the body a drug reaches and is expressed in terms of volume per unit of weight.
D. Clearance of a drug is usually through the liver.




Refer to Friend Refer to Friend